Over a year later, Musk’s Neuralink still 6 months from human trials

We've been here beforeThe event was said to be a general overview of the company's activities, and the presentations seemed to cover all of the key areas Neuralink is working on. But there wasn't anything dramatically new in the tech compared to the company's 2020 update, and it was difficult to piece the presentations together into a coherent picture of what the company plans to do with its hardware. But one of the Neuralink staff mentioned that the robot was a sticking point with the FDA, saying it's difficult to demonstrate its safety to the satisfaction of regulators.